Visiongain Publishes Transfection Reagent and Equipment Market Forecast 2020-2030

28 September 2020

Transfection Reagent and Equipment Market Forecast 2020-2030: Forecasts and Analysis By Method, By Application, By Product and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Transfection Reagent and Equipment sector analysis.

According to the report published by Visiongain, the Transfection Reagent and Equipment market is estimated to be valued at approximately USD 870 million in 2019 and is expected to grow at a CAGR of around 8.1% between 2020 and 2030. Transfection is the mechanism by which nuclear acids are inserted by non-viral approaches into eukaryotic cells. This gene transfer technology allows gene roles and protein expression to be studied in a cellular setting utilizing different chemical or physical approaches. Transfection uses have been significantly expanded by the design of reporter gene systems and selection procedures for safe preservation and expression of transfected DNA. Assay based technology provides the basis for the study of mammalian promoters and enhancer sequences, transacting proteins, such as transcription factors, mRNA processing, and protein, along with an extensive range of transfectional reagents. Development of recombinant technology & proteomics and the rising use by academic researchers of transfecting technology are some of the major developments that fuel market development. It is also planned that new reagents will be added to extend the use of transfection in various applications.

Transfection Reagent and Equipment Market is witnessing Growth due to factors such as

Transfection is one of the main research projects that lead to synthetic genetics studies.
Transfections can lead to the development of abnormal cells and unstable morphologies, but the mechanism can also be used to research the composition of genetic makeup and, through a deliberate invasion, change cell structures. Transfection has a crucial role in biomonitoring through the facilitation of research analyzes and bio-authenticity studies for regulatory approval of biopharmaceuticals. It innovation is therefore likely to be seeing both market and sales growth with the growing popularity of biopharmaceutical goods. Moreover, recently, the biopharmaceutical sector has seen a major patent cliff, with a patent expiration for several blockbuster biologics. As a result, many businesses have started to invest in the development of biosimilar biologic alternative products to address the risk of income loss. Therefore, by increasing the adoption rate of transfection software, the patent cliff risk has greatly benefited the business.

Shift in Trends

Transfection Methods Such as Laserfection Or Optoinjection Are Estimated To Boost The Growth Of The Equipment Segment.
Most of the transfection reagents include transfection kits for stem cells, transfection kits for siRNA, transfection buffers and optimisation kits for transfections. Various transfection methods involve the use of different reagents and thereby produce substantial revenue for the product. In terms of revenues, the reagents sector dominated the market. According to rising market acceptance levels of these reagents, this segment is expected to become important over the forecast period. Electroportation and electro fusion systems include transfection equipment. The volume of genomics-based research & development projects and the introduction of easy to use products like portable are rapidly rising. Owing to presence of expensive laser-based equipment used for different transfection methods such as laserfection or optoinjection are estimated to boost the growth of the equipment segment.

The Liposome Sector Is Expected To Post Notable CAGR During The Forecast Period
Livosomal transfer and particulate bombardment were closely followed in 2019 by electric company as the leading revenue share. Wide portfolios offered by large and emerging players for a range of electroporation solutions stimulate segment growth. In addition, the segment growth increases with a number of advantages, such as ease of use, variability and speed. The liposome sector is expected to post notable CAGR during the forecast period, with considerable participation in 2016. This method will likely be supported by a continued development of lipofection for increased in-vivo transfection efficiency.

The Income Generated From The Transfection Applications Is Projected To Significantly Increase, Contributing To Success On The Sector
In view of the increasing process volumes and the availability of a relatively large number of R&D projects, the income generated from the transfection applications is projected to significantly increase, contributing to success on the sector. Transfection reagents and devices studied are used in gene expression experiments, in the manufacture of proteins, in transgenic template development, in medicinal delivery, in biomedical research and in cancer research. The most prominent application segment in 2019 was gene expression studies. Expanding the genomic data pool and increasing emphasis on genomic information translation in clinical workflows lead to a significant share. Presence of a substantial number of ongoing research projects that aim at in-depth investigation of key mechanism, which underlie chromosomal anomalies, is also supplementing the growth of the segment.

Regional Market Analysis

North America was the market leader in 2019
Due to the presence of established biopharmaceuticals and genomics industries in the region, North America was the market leader in 2019. Among biological, cytological and oncological research institutions, there has been a heavy use of transfection technologies. Also leading to the development of the regional market is the existence of influential firms offering a variety of solutions to different end-useers in the area. The most rapid growth in the forecast period is expected in the Asia-Pacific region. Significant growth in the number of biopharmaceutical & clinical R&D programs, increasing medical research expenditure, and rising awareness regarding cytological and proteomic expressions are some of the key trends driving the regional market.

Competition in the market
The foreign demand for transfection reactives and equipment is projected to exhibit positive rate of growth in the next few years, largely due to recent developments in transfection engineering and the heavy effect on research and development activities on this sector by pharmaceutical and biotechnology organizations. The global reaction and equipment market also benefits from the newly established high-value alliances and partnerships, particularly between large pharmaceutical names and institutes of research, to boost drug discovery rates. The global demand for synthetic genes has seen and will probably continue to grow at a strong rate in the recent past. The study and growth efforts to combat cancer, an illness already highly prevalent in all countries, represent a significant part of this market.

Biotechnology firms, pharmaceutical companies, research institutes and educational institutions are the global market leading end users of transfection reagents and supplies. Viral, physical and biochemical are the main methods of transfection that this market can be segmented on. The video market would likely show a very positive growth trend in the next few years.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021


Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021


Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021


Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021